Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Non-Current Liabilities: 2023-2024

Historic Total Non-Current Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $658,000.

  • Zhengye Biotechnology Holding's Total Non-Current Liabilities was N/A to $649,788 in Q2 2025 from the same period last year, while for Jun 2025 it was $649,788, marking a year-over-year change of. This contributed to the annual value of $658,000 for FY2024, which is 55.21% down from last year.
  • According to the latest figures from FY2024, Zhengye Biotechnology Holding's Total Non-Current Liabilities is $658,000, which was down 55.21% from $1.5 million recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Total Non-Current Liabilities ranged from a high of $1.5 million in FY2023 and a low of $658,000 during FY2024.